✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹4,284 Cr.
P/E
144.36

Key Ratios

Market cap
Market cap
4,284 Cr
PE
PE
144
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
3.11
ROCE (%)
ROCE (%)
10.65
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1,602 Cr
OPM (%)
OPM (%)
10.73 %
Debt to Equity
Debt to Equity
-
About
Sequent Scientific is in the Miscellaneous sector with a M.cap of 4284.00 Cr and a PE … Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Sequent Scientific Ltd. Business

SeQuent, operating as Alivira Animal Health, is a global pharmaceutical company established in 2002. It focuses on developing products for livestock, poultry, and companion animals to create value in the animal health space.

Sequent Scientific major competitors are Guj. Themis Biosyn, Orchid Pharma, Gufic Biosciences, Zota Health Care, Unichem Lab, Panacea Biotec, Indoco Remedies.
Market Cap of Sequent Scientific is ₹4,263 Crs.
While the median market cap of its peers are ₹3,640 Crs.

Sequent Scientific seems to be less financially stable compared to its competitors.
Altman Z score of Sequent Scientific is 4.87 and is ranked 5 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material